Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension (Q46801144)

25 December 2017

title

Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension (English)

1 reference

25 December 2017

0 references

2

1 reference

25 December 2017

Henry Krum

1

object named as

Henry Krum

1 reference

25 December 2017

author name string

Emma Windebank

3

1 reference

25 December 2017

Duncan J Campbell

4

1 reference

25 December 2017

Murray Esler

5

1 reference

25 December 2017

publication date

11 November 2005

1 reference

25 December 2017

American Journal of Physiology Heart and Circulatory Physiology

published in

1 reference

25 December 2017

volume

290

1 reference

25 December 2017

issue

4

1 reference

25 December 2017

page(s)

H1706-12

1 reference

25 December 2017

Sympathetic overactivity as a cause of hypertension in chronic renal failure

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2005

Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2005

Evidence for the involvement of different receptor subtypes in the pre- and postjunctional actions of angiotensin II at rat sympathetic neuroeffector sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2005

Blood pressure and muscle sympathetic nerve activity during cold pressor stress: fitness and gender.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2005

Influence of brain renin-angiotensin system on renal sympathetic and cardiac baroreflexes in conscious rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2005

Rilmenidine sympatholytic activity preserves mental stress, orthostatic sympathetic responses and adrenaline secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2005

Brain angiotensin: on the way to becoming a well-studied neuropeptide system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2005

Interaction between presynaptic facilitatory angiotensin II receptors and inhibitory muscarinic cholinoceptors on 3H-noradrenaline release in the rabbit heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2005

Elevation of sympathetic activity by eprosartan in young male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2005

The interconnection between sympathetics, microcirculation, and insulin resistance in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2005

Adverse consequences of high sympathetic nervous activity in the failing human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2005

Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2005

Facilitation of noradrenaline release from sympathetic nerves in rat anococcygeus muscle by activation of prejunctional beta-adrenoceptors and angiotensin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2005

Hypoxic pHi and function modulation by Na+/H+ exchange and alpha-adrenoreceptor inhibition in heart in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2005

Facilitation of noradrenaline release by isoprenaline in rat isolated atria does not involve angiotensin II formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2005

Central inhibition of AT1receptors by eprosartan--in vitro autoradiography in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2005

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2005

Comparative effects of mibefradil and nifedipine gastrointestinal transport system on autonomic function in patients with mild to moderate essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2005

Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2005

Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2005

Angiotensin-II acts centrally to alter renal sympathetic nerve activity and the intrarenal renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2005

Angiotensin converting enzyme inhibition and sympathetic activity in healthy subjects*

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2005

10.1152/AJPHEART.00885.2005

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017